Aztreonam plus piperacillin - Empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy

Keyphrases

• Oncology Patients 100%
• Gynecologic Oncology 100%
• Cisplatin-based Chemotherapy 100%
• Empirical Therapy 100%
• Neutropenic Fever 100%
• Aztreonam 100%
• Piperacillin 100%
• Fever 33%
• Highly Active 33%
• Retrospective Analysis 33%
• Positive Culture 33%
• Cisplatin 33%
• Previously Treated 33%
• Antipseudomonal 33%
• Clinical Response 33%
• Gram-negative Bacteria 33%
• Antibiotic Therapy 33%
• Urine Culture 33%
• Blood Culture 33%
• Antibiotic Regimen 33%
• In Vitro Sensitivity 33%
• Penicillin 33%
• Ototoxicity 33%
• Prospective Evaluation 33%
• Nephrotoxicity 33%
• Neutropenic Patients 33%
• Antibiotic Combination 33%
• Febrile Episode 33%
• Fever Episode 33%
• Ototoxic Agents 33%
• Monobactam 33%
• Defervescence 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cisplatin 100%
• Chemotherapy Regimens 100%
• Febrile Neutropenia 100%
• Aztreonam 100%
• Piperacillin 100%
• Gram Negative Bacterium 33%
• Antibiotic Therapy 33%
• Ototoxicity 33%
• Nephrotoxicity 33%
• Monobactam Derivative 33%
• Antimicrobial Agent 33%
• Penicillin 33%

Medicine and Dentistry

• Monobactam 33%